Signal2026-08-06
ClinicalTrials.gov

[PHASE2] Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma

Part of

Emerging Clinical Immunotherapy And Treatment Trials

Open primary sourceSee the whole picture